RetinalGenix Technologies RTGN
OTC RTGN
$3.99 +0.00 (+0.00%)
At close: Nov 5, 2026 · 4:00 PM EST

RetinalGenix Technologies (RTGN) Net Equity Issued and Repurchased (2020 - 2026)

Updated

RetinalGenix Technologies (RTGN) reported Net Equity Issued and Repurchased of $200,000 for Q2 2026, up 132.6% from $86,000 a year earlier and up 60.0% from the prior quarter.

Analysis

RetinalGenix Technologies (RTGN) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, RetinalGenix Technologies' Net Equity Issued and Repurchased came in at $637,000, down 0.3% year-over-year; for FY2025, it was $548,000, down 23.2% from FY2024.

  • Net Equity Issued and Repurchased has a five-year compound annual growth rate of -17.0% (FY2020 to FY2025).
  • By year, Net Equity Issued and Repurchased came in at $713,088 in FY2024, $85,500 in FY2022 (-92.2%) and $1.1 million in FY2021 (-21.4%).
  • Five-year quarterly Net Equity Issued and Repurchased spans a low of $25,000 in Q3 2022 and a high of $305,043 in Q3 2024.
  • Year over year, Net Equity Issued and Repurchased gained in two of the last six quarters, with growth averaging 19.8%.
  • The high point for year-over-year Net Equity Issued and Repurchased in five years was Q2 2026 (growth of 132.6%); the low point was Q1 2022 (a decline of 84.8%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $125,000 (Q1 2026), $212,000 (Q4 2025) and $100,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Thermo Fisher Scientific 257.79 Bn 234.30 Bn 5.13 Bn -
2 Abbott Laboratories 190.83 Bn 164.70 Bn 7.39 Bn 89.00 Mn
3 Danaher 162.10 Bn 141.75 Bn 3.84 Bn -
4 Intuitive Surgical 158.05 Bn 138.34 Bn 2.08 Bn -2.88 Bn
5 Medtronic 130.31 Bn 95.56 Bn 6.34 Bn -247.00 Mn
6 Stryker 124.76 Bn 110.95 Bn 4.25 Bn -
7 Boston Scientific 62.03 Bn 57.46 Bn 3.43 Bn 95.00 Mn
8 Edwards Lifesciences 58.73 Bn 41.94 Bn 1.35 Bn -102.40 Mn
9 Becton Dickinson 58.33 Bn 55.48 Bn 2.32 Bn -
10 RetinalGenix Technologies 75.19 Mn 75.14 Mn - 200,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 200,000.00
Mar 31, 2026 125,000.00
Dec 31, 2025 212,000.00
Sep 30, 2025 100,000.00
Jun 30, 2025 86,000.00
Mar 31, 2025 150,000.00
Dec 31, 2024 98,045.00
Sep 30, 2024 305,043.00
Jun 30, 2024 160,000.00
Mar 31, 2024 150,000.00
Sep 30, 2022 25,000.00
Mar 31, 2022 60,500.00
Dec 31, 2021 258,934.00
Sep 30, 2021 162,792.00
Jun 30, 2021 276,876.00
Mar 31, 2021 398,097.00
Dec 31, 2020 343,810.00
API Access

RetinalGenix Technologies Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=RTGN&period=max&api_key=YOUR_API_KEY